Read, Learn, Innovate: Top Blog Posts from May 2019
ISPE
Featured in this edition of ISpeak Reading Roundup are the top blog posts from May 2019. Discover trending industry topics, developments for the future of pharma, and more for what the pharmaceutical industry was reading last month.
The pharma industry is ever-changing and developing new ways to move forward with science and technology. Pharma 4.0™ incorporates advanced technology to promote innovation and to provide more reliable and secure data. Learn how new technology and operations will propel the industry forward.
Consistency in reliable manufacturing and production systems is an increasingly necessary focus for pharmaceutical professionals in today’s industry. See how the pharma industry can meet new regulatory expectations and redefine good manufacturing practices in the age of complex technologies and treatments.
Biopharmaceutical production is readily adapting to new industry norms and creating opportunities for industry members to venture out of their comfort zone and embrace the future of biopharmaceuticals. Find out how biopharmaceutical production will change and what is expected from industry manufacturers.
This three-part water technology series reviews a redesigned system for increased product performance and cost reduction. Quality control and end-user perspectives of distillation procedures are addressed in this article.
Hear how risk management and FDA guidance can help ease the transition from past manufacturing procedures to complicated and multi-step manufacturing processes. The transition to and incorporation of new pharma tradition will prompt professionals to search for creative ways to overcome obstacles.
ISPE delivers technical and operational solutions to support across the global pharmaceutical and biopharmaceutical industry in the manufacture of quality medicines for patients.
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) has recently announced the adoption of the revised guideline
The outlook for the biopharmaceutical market is promising, with expectations that the market will double in the next 10 years, resulting in new therapies and advances in biopharmaceutical manufacturing. This doesn't sound like much at first, but if you consider how the market has developed over the last 20 years, a doubling in the next 10 years is very significant.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.